Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Regeneron Pharmaceuticals, Inc. (REGN) had Weighted-Average Shares Outstanding (Diluted) of 107.20M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.75B |
|
$1.46B |
|
$521.60M |
|
$3.23B |
|
$2.73B |
|
$1.03B |
|
$736.50M |
|
$1.76B |
|
$1.76B |
|
$1.46B |
|
$1.46B |
|
$1.46B |
|
$1.46B |
|
$1.03B |
|
$1.16B |
|
103.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
107.20M |
$14.09 |
|
$13.62 |
|
| Balance Sheet Financials | |
$17.98B |
|
$5.00B |
|
$22.19B |
|
$40.17B |
|
$4.43B |
|
$2.71B |
|
$4.79B |
|
$9.21B |
|
$30.96B |
|
$29.58B |
|
$30.96B |
|
105.30M |
|
| Cash Flow Statement Financials | |
$3.81B |
|
$-849.40M |
|
$-2.94B |
|
$2.49B |
|
$2.51B |
|
$24.10M |
|
$744.40M |
|
$-277.60M |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.06 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
86.11% |
|
27.35% |
|
27.35% |
|
-- |
|
46.97% |
|
38.89% |
|
$3.16B |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.16 |
|
0.66 |
|
136.33 |
|
4.72% |
|
4.94% |
|
3.63% |
|
4.34% |
|
$294.00 |
|
$29.46 |
|
$35.52 |
|